chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Broke out in hives - started on arm opposite of inject site and spread to legs/arms/all over body.  Took 2 benedryl
devel total body erythematous-macular rash-covers entire scalp, face & body-no changes in soaps, detergents or use of topical lotions or creams;
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a non-contactable reporter (Consumer or other non HCP). The reporter is the patient.  A 39-year-old female patient (not pregnant) received BNT162b2 (PFIZER/BIONTECH COVID-19 VACCINE), on 13Dec2021 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 38 years, in right arm for covid-19 immunisation; COVID-19 vaccine, as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication included: PROZAC. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Unknown results. Therapeutic measures were taken as a result of drug ineffective, covid-19 and included treatment with Paxlovid.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
felt weak; muscle pain on both their legs,; Tired; very bad headache; chills; This spontaneous case was reported by a physician and describes the occurrence of ASTHENIA (felt weak), FATIGUE (Tired), HEADACHE (very bad headache), CHILLS (chills) and MYALGIA (muscle pain on both their legs,) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013A21A) for COVID-19 vaccination.     The patient's past medical history included Pelvic fracture in September 2020 and Breast cancer (breast cancer from October 2020 to January 2021.) since October 2020. Concurrent medical conditions included Allergy (patient mentions they are allergic to several things). Concomitant products included POTASSIUM, PROPAFENONE HYDROCHLORIDE, TOPIRAMATE, DIAZEPAM, FAMOTIDINE, DIVALPROEX SODIUM and SOLIFENACIN SUCCINATE for an unknown indication.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced FATIGUE (Tired), HEADACHE (very bad headache) and CHILLS (chills). On 27-Feb-2021, the patient experienced ASTHENIA (felt weak) and MYALGIA (muscle pain on both their legs,). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and TRAMADOL for Headache, at an unspecified dose and frequency. At the time of the report, ASTHENIA (felt weak), FATIGUE (Tired), HEADACHE (very bad headache), CHILLS (chills) and MYALGIA (muscle pain on both their legs,) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
No adverse event; Patient was administered pediatric monovalent vaccine instead of bivalent booster; This spontaneous case was reported by a pharmacist and describes the occurrence of WRONG PRODUCT ADMINISTERED (Patient was administered pediatric monovalent vaccine instead of bivalent booster) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. AR6965B) for COVID-19 prophylaxis.     No Medical History information was reported.    On 21-Dec-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 21-Dec-2022, the patient experienced WRONG PRODUCT ADMINISTERED (Patient was administered pediatric monovalent vaccine instead of bivalent booster). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (Patient was administered pediatric monovalent vaccine instead of bivalent booster) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (Patient was administered pediatric monovalent vaccine instead of bivalent booster).    Concomitant product use was not provided by the reporter. This case was for patient 13 of 16. Treatment information was not provided.   This case was linked to US-MODERNATX, INC.-MOD-2022-692175 (Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2022-692175:master case((same reporter)
16 hours later had sever nausea- dry heaving- temperature to 101.9-  head and severe body / joint aches
Rash on lower legs and feet.  No pain No itching  No swelling on feet Some swelling on right  Started in last 24 hrs. Seeking treatment.
The patient received Pfizer vaccine on 04/28/21 and Johnson & Johnson on  05/06/21
This case was reported by a physician and described the occurrence of Bell's palsy in a 59 year old female subject who was vaccinated with influenza virus vaccine (Fluarix) for prophylaxis. The subject had no pre-existing medical conditions and is a non-smoker. There were no concurrent medications. The subject had received influenza virus vaccine (unknown manufacturer) in previous years with no adverse events following receipt of the vaccination. On 03 November 2005 at 3:00 pm, the subject received a dose of Fluarix in the left arm (lot AFLUA138BA). At 3:20 am on 04 November 2005, 12 hours after vaccination with Fluarix, the subject experienced Bell's palsy. The subject was seen at a physician's office and was treated with steroid (Steroids). The event resolved "within 3 days." on an unspecified date in November 2005. The physician considered the event to be clinically significant (or requiring intervention) (OMIC). The physician reported that he "will advise against future influenza vaccinations." The physician considered the Bell's palsy to possibly be related to vaccination with Fluarix.
Patient's daughter called pharmacy on 02/24/2022 to notify her mom received Moderna Booster 02/17/2022 and started having rash on torso on 02/19/2022.  The rash was reported and itchiness with no pain. The rash gradually worsen over time and was spreading to her face and scalp on 02/24/2022. Daughter stated he mom tried 4 tablets of diphenhydramine and it did not help with the itchiness nor did it help with the rash spreading. Atarax 25mg was written for the patient. Patient told that if symptoms worsen or included difficulty breathing to go to the emergency room
Day 1: brain fog + swollen arm + patching rash  Day 2: sore arm + migraine Day 3:  sore arm + migraine Day 4:  slightly less sore of a arm + now other Joints getting jolts of pain  + burning feeling back of head  Day 5 :bad reaction to when drink 1 beverage of alcohol  Day 6: feels like a cluster head ach at bottoms of head  Day 7:  brain fog +  achy body + body feels itchy Day 8:  drank another alcoholic beverage and felt like I was going to pass out when walking  Day 9:  swelling around injection site+ red ring around it +itchy  Day 10 intense joint pain hip, knees, ankles + ringing in ears Day 11 lamp on back of head + pain at back of head when moving, The lump is not visible and is on the left back side  Day 12: head pain and lump still presents + stiff joints
Patient reports following injection,, she walked away from vaccination station to the recovery area, where she sat down and got an overwhelming urgency to use the bathroom for bowel movement.  Patient reports due to weakness she did not ambulate to the bathroom and asked for help.  Patient reports that she experienced "burning" sensation in the left arm and throughout torso.  Patient then states that she could not stop falling asleep.  Patient does not recall any events after this before arrival of public health staff.
Chill beginning Friday morning then Saturday morning woke up nauseous and very bad diarrhea - lasted until about 3 pm.  It came in ?waves?. Also very tired on Saturday.
Felt sick; Had a fever; Body ached; Headache; Feeling weak; This is a spontaneous report from a contactable consumer (patient) reported that:  A 55-years-old female patient received bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: not reported), (At the age of 55 years) via an unspecified route of administration on an unspecified date as DOSE 1, SINGLE for covid-19 immunisation. The patient was scheduled for her second Covid 19 vaccine on 17May2021. The patient medical history was not reported. The patient's concomitant medications were not reported. About 2 weeks after receiving her Covid 19 vaccine. On an unspecified date, the patient had experienced feeling really sick, Fever, body aches, headaches and feeling kind of weak. At the time of reporting, the outcome of the events were unknown.   No follow-up attempts are needed; No further information expected.
Urticaria 12 days after administration of vaccines; no other known triggers. Suspect due to live virus vaccine (MMR).
No problem the first day. Next morning patient had tenderness or pain at needle site. Changed to pain if touched. Pain was from shoulder to about 2 inches above elbow. Swelling began to go down after taking ibuprofen and cold pack. I t was still tender.
This spontaneous report as received from a healthcare worker refers to a 12 year old patient of unknown gender. There was no information about patient's concomitant medications and pertinent medical history reported. On 08-JUL-2015, the patient was vaccinated with an improperly stored dose of GARDASIL (lot# K023432 expiration date 18-JUN-2016) (strength, dose, route and site of administration were not provided). No adverse effects reported. This is one of several reports from the same reporter. Additional information has been requested.
The Moderna vaccine administration was painful at the time the shot was received. I experienced symptoms of fatigue and body aches for 24 hours after receiving the vaccine. My left arm was extremely sore and knotted for over a week after administration. The vaccine site was red and splotchy for the first 7 days after getting the shot. By the early morning of the 8th day (01/16/21), the splotches had joined together to make a large red area surrounding the vaccine site, that was raised and hot to the touch. During that entire day, pain was shooting down my left arm to my fingers (particularly the left middle finger) in a manner that felt like how severe arthritis pain is described. The pain became worse as the day went on. I texted a picture of my arm to my boss, who is a physician, to see what he thought I should do. He stated that from the photo, it looked like Cellulitis, and offered to send in an antibiotic to my pharmacy. Soon after, the pain was so intense (especially with movement of the arm) that I had someone drive me to  ER & Urgent Care around 8:30pm. The physician there marked my arm and prescribed 2 antibiotics to begin taking immediately (Bactrim & Amoxicillin) with the instructions to come back in 48 hours. By the next day, the redness was spreading by the hour, which was marked & tracked via photos that documented the progression. By Monday morning, the redness had continued to spread & take up most of my left upper arm. The skin was hot to the touch and swollen. I had my boss look at my arm in the morning and mark the redness, then I had another physician at my office look at it in the afternoon and do the same. Their analysis was that the antibiotics were not working, and I went back to  ER after I got off work at 5pm, which was around the 48-hour mark when I was supposed to return.  ER gave me several IV antibiotics and ordered an Ultrasound of the left arm to make sure there was no blood clot hidden beneath the swelling.  They also took several different lab and blood culture samples. I ended up having a reaction to one of the IV antibiotics (Vancomycin), where they had to counteract the reaction with IV steroids & antihistamines, and decided to hold off on giving me the third IV antibiotic that was initially planned. I was sent home with Clindamycin 900mg, a Medrol dosepack, and told to discontinue the Bactrim, but continue the Amoxicillin. I continued to check back over the following days, and ended up receiving another IV antibiotic (Clindamycin) and more lab tests. The provider that saw me on Monday said that she was close to admitting me to the hospital, and if I did not improve by the following day, she would proceed with sending me. By the 5th/6th day, the redness seemed to be improving and becoming smaller.
On November 16, 2021 at 6:00 a.m.,  I broke out in full blown hives all over my body.  I took a Benadryl and then Allegra.  I have had continued hives, shortness of breath ( with a lung function of 44 % in the small bronchioles), and coughing.  I have had two separate emergency room visits on November 19 and on November 30th. I saw my internist on November 24th and she prescribed Allegra, Protonix, Pepcid AC, and Albuterol inhaler.  I saw a pulmonologist on December 2nd who prescribed  a short term course of prednisone ( 40 mg  daily for 5 days) and the Duo Inhaler.  I saw an allergist on December 8th who had switched my DUO inhaler to the QVAR inhaler.  No one seems to know what is causing my reaction. I saw my internist, Dr. for my regular physical on November 12th-I  had no breathing problems, hives, coughing at that visit.  I was fine before November 16th and only took Synthroid and a multivamin. My world changed on November 16 th and is unexplained to everyone that I have seen.  Folks are only treating my symptoms, but I am discouraged with my shortness of breath on lung exhalation.  Have other folks had a reaction to the Moderna Booster?  I am currently taking Protonix, Allegra, Albuterol inhaler, Qvar inhaler and Pepcid AC whereby I formerly have not had any breathing issues.  Please help!
Approximately 16 hours after receiving the vaccine I began to feel very lethargic. I stayed in bed most of the day, feeling chills, then heat, along with pain in my lower legs. I was not very hungry or thirsty either. I started feeling better around 9 p.m. on April 27, and the following day (April 28), I was pretty much back to normal. However, I was experiencing bouts of diarrhea.
Pt developed fever and rash, 4 weeks, post vax, with increased respiratory difficulty; by the 5th week,requiring assisted ventilation.  Diagnosed with Varicella pneumonia
Patient admitted for planned left atrial appendage closure device (watchman) placement due to high risk of bleeding secondary to falls and syncope while on anticoagulation for PAF. She had no complications post-operatively. Hospital admission within 6 weeks of receiving the COVID vaccine.
Tingling in the ears/Experienced sensations in ears; dizziness; Nervous problem in ears; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (Tingling in the ears/Experienced sensations in ears), EAR DISCOMFORT (Nervous problem in ears) and DIZZINESS (dizziness) in a 38-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-May-2021, the patient experienced PARAESTHESIA (Tingling in the ears/Experienced sensations in ears) and DIZZINESS (dizziness). On an unknown date, the patient experienced EAR DISCOMFORT (Nervous problem in ears). At the time of the report, DIZZINESS (dizziness) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This case was linked to MOD-2021-106762 (Patient Link).
Information has been received from a nurse practitioner, concerning a 14 years old patient of unknown gender. Patient's historical condition, current condition, concomitant medication, previously drug reactions and allergies were not reported. On 04-MAR-2019, the patient was administered with a dose of PROQUAD subcutaneous injection for prophylaxis (anatomical location, lot number and expiration date were not reported) (product use in unapproved population). No adverse effects were reported. This is one of two reports received from the same source.; Sender's Comments: US-009507513-1903USA002615:
0400 woke up freezing, 102.7 temp, nauseated, body aches, weakness, fatigue, dizziness, rash
patient was administrated with and expired dose / vaccine expired on March 5 2021; This case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 20-year-old female patient who received HBV (Engerix B) (batch number unknown, expiry date 5th March 2021) for prophylaxis.   On 15th June 2021, the patient received Engerix B. On 15th June 2021, unknown after receiving Engerix B, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.  Additional details were provided as follows: The physician assistance reported that, the patient received expired dose of Engerix B, which led to expired vaccine used No adverse event was reported .  The reporter did not consent to follow-up.
Blisters; pain in the area of the shoulder on the area of the shoulder of the arm that I received this shot; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 47 year-old male patient received bnt162b2 (BNT162B2), administration date 08May2021 (Batch/Lot number: unknown) at the age of 47 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "High blood pressure" (unspecified if ongoing), notes: Verbatim: High blood pressure. Concomitant medication(s) included: AMLODIPINE taken for blood pressure measurement. The following information was reported: BLISTER (non-serious), outcome "unknown", described as "Blisters"; VACCINATION SITE PAIN (non-serious), outcome "unknown", described as "pain in the area of the shoulder on the area of the shoulder of the arm that I received this shot". Therapeutic measures were taken as a result of vaccination site pain.  Additional Information: Patient stated, Yesterday he had taken the Pfizer vaccine shot, wich was the first one, he had taken  yesterday (confirmed as 8May2021) and today, patient had experienced pain in the area of the shoulder on the area of the shoulder of the arm that he had received vaccine shot, but he had blister afternoon ago but he was just wondering if that was normal to have blister in all the area also too." Patient stated, "No, well the pain was diminished a little bit because  he had taken a Tylenol for pain, extra strength Tylenol, and yes some of the pain got diminished,  as he was in pain so  had taken a pill for pain."  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
She reported a headache that lasted for 2 weeks with weakness for 1 week. Relieved with Motrin but came back.
Information has been received from a pharmacist concerning a 79 year old female who on 11/12/01 was vaccinated with pneumococcal vaccine 23 polyvalent (lot #639394/0461L). Subsequently the patient developed swelling (unspecified), swelling of the arm, redness, and cellulitis. Medical attention was sought and thepatient was prescribed antibiotics. At the time of this report, the outcome of the events were unknown. Per request of the pharmacist, a request for a lot check has been made. The records of testing prior to release of this lot have been check and found to be satisfactory. The lot complies with the standards and was released. Additional information has been requested. Related WAES01112443.
developed a pruritic red burning rash on hands and arms 1 hour and 23 minutes after Pfizer covid vaccine. Itching all over and mild itchiness of throat.  Had premeditated with 10mg zyrtec.  Upon reaction took additional 10mg zyrtec and prednisone 10mg.  symptoms resolve in 4 hours
Drained much green discharge prior to coming this day, left arm with area of induration, dimpled. Symptoms initially were warm, tender area, enlarged 1 wk after Td immunization. It decreased to knot then increased in size again.
Dizziness beginning 24 hours after the second injection. This has continued for the past 11 days.
I tested positive for COVID-19 around 11/18/2021. I had a breakthrough case.
woke up from nap feeling warm did not take temp; gave 2 APAP tabs; around 6PM acting strangely, staring, drooling, twitching, turned blue (10-15 mins), t102.8; also pinpoint rash on abdo;
Could not breathe my nose and the back of my throat plugged up had to breathe out of my mouth. Had to call the doctor got some fluticasone nose spray
Pt was seen out of the provider's peripheral vision to start falling to the floor (vaccine was given while seated about 5 minutes previously). Pt was then seen on floor with seizure-like movements of head and upper limbs for 5-10 seconds. It is possible the patient struck his head when falling against fire extinguisher on the wall or the wall itself. Pt regained consciousness with no memory of event. Felt ill. Given 50mg Benadryl PO in case of allergic rxn. Had headache immediately after fall and felt nauseated but no vomiting. Vital signs were within normal limits following incident. Rescue was called and transported pt to hospital ER.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 68-year-old male patient received BNT162b2 (BNT162B2), on 31Oct2021 at 11:00 as dose 3 (booster), single (Lot number: fc3100) at the age of 67 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Hypertension" (unspecified if ongoing); "hyperlipidism" (unspecified if ongoing); "type II diabetes" (unspecified if ongoing). There were no concomitant medications. Patient had no known allergies. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (unspecified date) Positive; (unspecified date) Positive, notes: rebound covid after testing negative; (24Sep2022) Negative, notes: rebound covid after testing negative 2 days in a row 24Sep2022 and 25Sep2022; (25Sep2022) Negative, notes: rebound covid after testing negative 2 days in a row 24Sep2022 and 25Sep2022. Therapeutic measures were taken as a result of drug ineffective, covid-19.